Zai Lab Limited ADR (ZLAB) concluded trading on Thursday at a closing price of $33.18, with 4.23 million shares of worth about $140.26 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 110.80% during that period and on October 24, 2024 the price saw a gain of about 14.65%. Currently the company’s common shares owned by public are about 99.12M shares, out of which, 98.53M shares are available for trading.
Stock saw a price change of 25.87% in past 5 days and over the past one month there was a price change of 63.13%. Year-to-date (YTD), ZLAB shares are showing a performance of 21.41% which increased to 32.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.48 but also hit the highest price of $31.22 during that period. The average intraday trading volume for Zai Lab Limited ADR shares is 680.52K. The stock is currently trading 26.60% above its 20-day simple moving average (SMA20), while that difference is up 48.91% for SMA50 and it goes to 69.31% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zai Lab Limited ADR (NASDAQ: ZLAB) currently have 99.12M outstanding shares and institutions hold larger chunk of about 42.56% of that.
The stock has a current market capitalization of $3.29B and its 3Y-monthly beta is at 1.06. It has posted earnings per share of -$3.07 in the same period. It has Quick Ratio of 3.29 while making debt-to-equity ratio of 0.12. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ZLAB, volatility over the week remained 5.92% while standing at 5.60% over the month.
Stock’s fiscal year EPS is expected to rise by 13.27% while it is estimated to increase by 39.04% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on December 14, 2023 offering an Overweight rating for the stock and assigned a target price of $47.50 to it. Coverage by Cantor Fitzgerald stated Zai Lab Limited ADR (ZLAB) stock as an Overweight in their note to investors on August 10, 2023, suggesting a price target of $70 for the stock. Stock get a Buy rating from Goldman on April 28, 2020.
